Business Description
Zynex Inc
NAICS : 423460
SIC : 5122
ISIN : US98986M1036
Total Employee Number:
1,000Compare
Compare
Traded in other countries / regions
ZYXIQ.USA Index Membership
Russell 3000Russell 2000 IPO Date
2002-12-31Description
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.19 | |||||
Equity-to-Asset | -0.91 | |||||
Debt-to-Equity | -1.73 | |||||
Debt-to-EBITDA | -1.13 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -5 | |||||
Beneish M-Score | -6.59 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 21.5 | |||||
3-Year EBITDA Growth Rate | -19 | |||||
3-Year EPS without NRI Growth Rate | -41.1 | |||||
3-Year FCF Growth Rate | 32.4 | |||||
3-Year Book Growth Rate | -15.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 35.38 | |||||
9-Day RSI | 41.76 | |||||
14-Day RSI | 42.97 | |||||
3-1 Month Momentum % | 32.35 | |||||
6-1 Month Momentum % | -93.79 | |||||
12-1 Month Momentum % | -96.34 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.47 | |||||
Quick Ratio | 0.32 | |||||
Cash Ratio | 0.17 | |||||
Days Inventory | 160.23 | |||||
Days Sales Outstanding | 47.72 | |||||
Days Payable | 105.64 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 7.1 | |||||
Shareholder Yield % | 444.03 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 71.64 | |||||
Operating Margin % | -34.35 | |||||
Net Margin % | -68.35 | |||||
EBITDA Margin % | -58.54 | |||||
FCF Margin % | -19.41 | |||||
OCF Margin % | -19.01 | |||||
ROE % | -709.17 | |||||
ROA % | -76.22 | |||||
ROIC % | -47.81 | |||||
3-Year ROIIC % | 197.26 | |||||
ROC (Joel Greenblatt) % | -222.29 | |||||
ROCE % | -121.52 | |||||
Years of Profitability over Past 10-Year | 9 | |||||
Moat Score | 4 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 0.25 | |||||
Shiller PE Ratio | 3.55 | |||||
PS Ratio | 0.02 | |||||
EV-to-EBIT | -0.88 | |||||
EV-to-EBITDA | -0.95 | |||||
EV-to-Revenue | 0.55 | |||||
EV-to-Forward-Revenue | 0.59 | |||||
EV-to-FCF | -2.86 | |||||
Price-to-GF-Value | 0.01 | |||||
Price-to-Projected-FCF | 0.1 | |||||
Price-to-Median-PS-Value | 0.01 | |||||
Earnings Yield (Greenblatt) % | -113.64 | |||||
FCF Yield % | -1240.22 | |||||
Forward Rate of Return (Yacktman) % | 495.45 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:ZYXIQ
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Zynex Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 108.202 | ||
| EPS (TTM) ($) | -2.43 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | -1.09 | ||
| 3-Year Sortino Ratio | -1.16 | ||
| Volatility % | 141.7 | ||
| 14-Day RSI | 42.97 | ||
| 14-Day ATR ($) | 0.023956 | ||
| 20-Day SMA ($) | 0.068453 | ||
| 12-1 Month Momentum % | -96.34 | ||
| 52-Week Range ($) | 0.0203 - 2.82 | ||
| Shares Outstanding (Mil) | 30.78 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Zynex Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Zynex Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-18 09:00 | In 140 days | ||
| Third quarter earnings results for 2026 | 2026-11-17 | In 138 days | ||
| Second quarter earnings conference call for 2026 | 2026-07-31 16:15 | In 30 days | ||
| Second quarter earnings results for 2026 | 2026-07-31 | In 29 days | ||
| General meeting for 2026 | 2026-05-15 09:00 | 0.05 (+0.00%) | ||
| First quarter earnings conference call for 2026 | 2026-04-29 16:15 | 0.05 (+0.00%) | ||
| First quarter earnings results for 2026 | 2026-04-29 | 0.05 (+0.00%) | ||
| Annual report for 2025 | 2026-04-08 | 0.05 (+0.00%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-04-01 16:15 | 0.05 (+0.00%) | ||
| Fourth quarter earnings results for 2025 | 2026-04-01 | 0.05 (+0.00%) |
Show
Entries
Zynex Inc Frequently Asked Questions
What is Zynex Inc(ZYXIQ)'s stock price today?
The current price of ZYXIQ is $0.06. The 52 week high of ZYXIQ is $2.82 and 52 week low is $0.02.
When is next earnings date of Zynex Inc(ZYXIQ)?
The next earnings date of Zynex Inc(ZYXIQ) is 2026-07-31 Est..
Does Zynex Inc(ZYXIQ) pay dividends? If so, how much?
Zynex Inc(ZYXIQ) does not pay dividend.
Guru Commentaries on OTCPK:ZYXIQ
No articles.
Press Release
Articles on Zynex Inc
No articles.